Differential clinical responses to everolimus-eluting and Paclitaxel-eluting coronary stents in patients with and without diabetes mellitus.

@article{Stone2011DifferentialCR,
  title={Differential clinical responses to everolimus-eluting and Paclitaxel-eluting coronary stents in patients with and without diabetes mellitus.},
  author={Gregg Whitney Stone and Elvin Kedhi and Dean J Kereiakes and Helen Parise and Martin Fahy and Patrick Washington Serruys and P. C. Smits},
  journal={Circulation},
  year={2011},
  volume={124 8},
  pages={893-900}
}
BACKGROUND Some (but not all) prior trials have reported differential outcomes after percutaneous coronary intervention with paclitaxel-eluting stents versus stents eluting rapamycin analogs according to the presence of diabetes mellitus. These studies lacked sufficient power to examine individual safety and efficacy end points. METHODS AND RESULTS To… CONTINUE READING